Melbourne, July 24, 2008 (ABN Newswire) - Biota Holdings Limited (ASX:BTA)(PINK:BTAHY) today announced that it had received written notification from GlaxoSmithKline (LON:GSK)(PINK:GLAXF) that indicative royalties from Relenza were $0.4m during the three months ended 30 June 2008, on sales of $6.2m.
